Saturday, April 5, 2025
| 7:00 - 7:50 AM | REGISTRATION / BREAKFAST / EXHIBITS | |||||
| 7:50 - 8:00 AM | Welcome & Announcements | |||||
| 8:00 - 9:55 AM | SESSION ONE: Unlocking the Secrets of Early Cancer Detection: Cutting-edge Strategies for the Next Frontier in Pancreaticobiliary Oncology Moderator: N. Jewel Samadder, MD, MS Stephen B. Gruber, MD, PhD Cristian Tomasetti, PhD Michelle A. Anderson, MD, MSc Jordan Iannuzzi, MD Panel Discussion | |||||
| THE FOLLOWING 3 SESSIONS ARE NON-CME ACCREDITED. | ||||||
| 9:05 - 10:05 AM | REFRESHMENT BREAK/EXHIBITS | |||||
| 10:05 - 10:35 AM |
| |||||
| 10:35 - 10:40 AM | Transition to the General Session | |||||
| 10:40 AM - 12:15 PM | SESSION TWO: United Front: Multidisciplinary Strategies for Conquering Colorectal Liver Metastasis Moderator: Marwan Fakih, MD Gagandeep Singh, MD Maarouf A. Hoteit, MD Jonathan Kessler, MD Panel Discussion | |||||
| THE FOLLOWING 5 SESSIONS ARE NON-CME ACCREDITED. | ||||||
| 12:15 - 12:30 PM | LUNCH | |||||
| 12:30 - 1:15 PM | SATELLITE SYMPOSIUM by AstraZeneca Key Considerations When Choosing a First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Jonathan Mizrahi, MD | |||||
| 1:15 - 1:45 PM |
| |||||
| 1:45 - 2:05 PM | PRODUCT THEATER by Amgen FGFR2b Protein Overexpression: An Emerging IHC-Base Biomarker in G/GEJ Cancer Michelle K. Gleason, PhD MS | |||||
| 2:05 - 3:35 PM | SESSION THREE: | |||||
| 3:35 PM | ADJOURN | |||||
| 3:45 - 5:45 PM | MEET THE FACULTY RECEPTION | |||||
Sunday, April 6, 2025
| 7:00 - 8:15 AM | REGISTRATION / BREAKFAST / EXHIBITS | |||||
| 8:15 - 8:20 AM | Welcome & Announcements | |||||
| 8:20 - 9:50 AM | SESSION FOUR: Precision Paradigms: Redefining GI Cancer Management through Targeted Diagnostics and Therapies Moderator: Ajaz M. Khan, MD, MBA Kun-Hsing Yu, MD, PhD Pashtoon Kasi, MD, MS Sameer Keole, MD Panel Discussion | |||||
| THE FOLLOWING 3 SESSIONS ARE NON-CME ACCREDITED. | ||||||
| 9:50 - 10:00 AM | REFRESHMENT BREAK/EXHIBITS | |||||
| 10:00 - 10:30 AM |
| |||||
| 10:30 - 10:35 AM | Transitioning to the General Session | |||||
| 10:35 AM - 12:00 PM | SESSION FIVE: Next-Gen Dialogues in GI Oncology: Pioneering Digital Frontiers and Equity Moderator: Vivek Kaul, MD Hannah Farfour, DNP, AGPCNP-BC Sarah Enslin, PA-C Gregory Idos, MD, MS | |||||
| THE FOLLOWING 5 SESSIONS ARE NON-CME ACCREDITED. | ||||||
| 12:00 - 12:15 PM | LUNCH | |||||
| 12:15 - 12:35 PM | PRODUCT THEATER by Steris Liquid Nitrogen for Treatment of Esophageal Cancer - HOW COOL IS THAT? Michael S. Smith, MD, MB | |||||
| 12:40 - 1:00 PM | PRODUCT THEATER by Guardant Health Methylation based ctDNA analysis for the detection of molecular residual disease (MRD) in stage II+ CRC Brandon Guida PhD, MS, McS, MB | |||||
| 1:00 - 1:30 PM |
| |||||
| 1:30 - 3:25 PM | SESSION SIX: Collaborative Precision: Organ Preservation Next Frontier Moderator: Pashtoon Kasi, MD, MS Emre Gorgun, MD, MBA Steven H. Lin, MD, PhD Michael S. Smith, MD, MBA Neil R. Sharma, MD Panel Discussion | |||||
| 3:25 PM | CONFERENCE ADJOURNS | |||||

Facebook
X
LinkedIn
Forward